Delic Labs, based in Vancouver, Canada, specialises in chemical process development, analytical testing and extraction optimisation. The company was originally founded in 2018 by Dr Markus Roggen and Prof. Dr Glenn Sammis and was renamed following its sale to the DELIC Group. Since its inception, the company has focused on advancing the cannabis and psilocybin industries through collaborative research and fundamental science.
Further information about Delic Labs can be found here.
